Zumutor receives the US patent for its novel biologic ZM008
Zumutor is happy to announce that it received a [...]
Zumutor Receives FDA Response on Pre-Investigational New Drug (PIND) Application
Zumutor Receives FDA Response on Pre-Investigational New Drug (PIND) [...]
Abrogation of natural killer cell check point pathway LLT1/CD161 by novel anti LLT1 antibody ZM008 and its therapeutic applications in solid cancers.
Maloy Ghosh, Sanghamitra Bhattacharjee, Anurag Tiwari, Ashvini Kumar Dubey, [...]
INABLRS® – End to end antibody discovery platform
Major strategies for mining human antibody repertoires are: a) [...]
Training a Natural Killer!
- By Aniket Bangroo, Kirthana MV Sindhe and Subhra [...]
Advances in Metastatic Castration Resistant Prostate Cancer (mCRPC) Management
- By Sonali Karhana - Despite recent diagnostic and therapeutic [...]